Glaukos

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.

About GKOS

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.

CEO

Thomas William Burns

CEOThomas William Burns

Employees

907

Employees907

Headquarters

Aliso Viejo, California

HeadquartersAliso Viejo, California

Founded

1998

Founded1998

Employees

907

Employees907

GKOS Key Statistics

Market cap

4.97B

Market cap4.97B

Price-Earnings ratio

-35.57

Price-Earnings ratio-35.57

Dividend yield

—

Dividend yield—

Average volume

464.49K

Average volume464.49K

High today

$102.95

High today$102.95

Low today

$95.37

Low today$95.37

Open price

$95.37

Open price$95.37

Volume

664.48K

Volume664.48K

52 Week high

$103.66

52 Week high$103.66

52 Week low

$45.38

52 Week low$45.38

GKOS News

TipRanks 12h

Glaukos First-Quarter 2024 Financial Performance Overview - TipRanks.com - TipRanks

Glaukos (GKOS) has shared an update. Glaukos Corporation has released its first-quarter financial summary for 2024, offering investors a glimpse into the compa...

Analyst ratings

67%

of 15 ratings

Buy

66.7%

Hold

33.3%

Sell